The easiest to be mistaken for is not who has gained the most, but whose shorts are still holding on stubbornly.


$BABY +32.1% is the most dramatic.
Trading volume reached $357 million, and open interest surged by 245%, this is not an ordinary follow-through pulse.
More importantly, the funding rate is still at -0.085%, shorts are paying to hold the rise, and the longer the order book drags on, the easier it is to be squeezed out by large fluctuations.
$CLO +36.4% is the biggest gain today.
1-hour open interest increased by 43.4%, indicating that it’s not just the price drifting on its own, but positions are really piling in.
The long-short ratio is 1.55, leaning long, with a trading volume of $34 million, not top-tier, but this small-cap high-elasticity structure is most easily underestimated for its continuation by the market.
$BTW +28.2% should not be seen as just a rebound.
Online trading volume is $349 million, and open interest increased by 48.8%, indicating that funds are not just lightly sweeping in and out.
The long-short ratio is only 0.66, which is somewhat counter to consensus; prices are rising, but account structures are not that crowded. This order book is more interesting than it appears.
Top 4-10 briefly: ALLO +26.9%, VELVET +23.5%, BAS +20.7%, VVV +13.3%, Lobster +13.0%, TUT +12.5%, NFP +11.3%.
Today’s main theme is very clear: funds are concentrating their strength in a few high-volatility names, not a market-wide rally.
The short squeeze candidates are still focused on BABY, with negative funding rates combined with exploding open interest, shorts are already bearing extreme costs.
For continuation, watch $BABY, $CLO, and $BTW; the most informative signals in today’s contract market are among these three. #ContractObservation
This content is generated with the assistance of Claude Opus 4.8, for informational purposes only. Please verify independently.
CLO17.25%
BTW3.93%
ALLO20.66%
VELVET20.1%
View Original
post-image
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned